Today's most important upgrades
- ByInvesting.com-
BofA Securities upgraded TransUnion (NYSE:TRU) to Buy from Neutral and raised its price target to $91.00 from $72.00, noting that a recession is priced in, and the company's...
Symbol | Exchange | Currency |
|---|
BofA Securities upgraded TransUnion (NYSE:TRU) to Buy from Neutral and raised its price target to $91.00 from $72.00, noting that a recession is priced in, and the company's...
Investing.com - NeoGenomics (NASDAQ:NEO) reported on Tuesday third quarter earnings that beat analysts' forecasts and revenue that topped expectations. NeoGenomics announced...
Biotechnology stocks represent companies that research, develop or market healthcare-related therapies or products. They typically use living organisms, biological systems, or...
Small-cap stocks are companies with a market capitalization between $300 million and $2 billion. Historically, such stocks have performed better than large-cap stocks, especially...
SPECIAL ALERT: The biotech sector is projected to surge beyond $2.4 trillion by 2028 as scientists develop treatments for thousands of diseases. They’re also finding ways...
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories. The Company operates through two segments: the Clinical Services Segment and the Pharma Services Segment. The Clinical Services segment provides various clinical testing services to community-based pathology practices, oncology practices, hospital pathology labs, reference labs, and academic centers with reimbursement from various payers, including client direct billing, commercial insurance, Medicare and other government payers, and patients. The Pharma Services segment supports pharmaceutical firms in their drug development programs by providing testing services and data analytics for clinical trials and research. It offers testing services, which include cytogenetics, fluorescence in-situ hybridization (FISH), flow cytometry, immunohistochemistry (IHC) and digital imaging, molecular testing and morphologic analysis. It operates testing laboratories in United States, Europe and Asia.
| Average | 15.78 (+26.22% Upside) |
| High | 26.00 |
| Low | 10.00 |
| Price | 12.50 |
| No. of Analysts | 9 |
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Buy | Strong Buy | Strong Buy | Strong Buy | Sell |
| Technical Indicators | Neutral | Strong Buy | Strong Buy | Strong Buy | Strong Sell |
| Summary | Neutral | Strong Buy | Strong Buy | Strong Buy | Strong Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 145.43 | 146.61 | 141.32 | +1.14 | +0.79% | 76.45M | NASDAQ | |||
| 100.43 | 101.19 | 97.58 | +1.59 | +1.61% | 32.95M | NASDAQ | |||
| 105.15 | 106.24 | 101.24 | +2.02 | +1.96% | 75.35M | NASDAQ | |||
| 209.43 | 211.92 | 196.11 | +14.06 | +7.20% | 65.36M | NASDAQ | |||
| 84.64 | 85.48 | 77.88 | +9.49 | +12.63% | 151.32M | NASDAQ | |||
| 112.82 | 113.95 | 110.15 | +2.62 | +2.38% | 16.50M | NYSE | |||
| 36.43 | 36.56 | 35.61 | +0.540 | +1.50% | 108.60K | OTC Markets | |||
| 230.90 | 232.66 | 227.80 | +0.69 | +0.30% | 5.78M | NYSE | |||
| 138.46 | 139.94 | 132.68 | +5.25 | +3.94% | 10.40M | NASDAQ | |||
| 62.60 | 63.23 | 60.38 | +2.30 | +3.81% | 20.81M | NASDAQ | |||
| 109.99 | 110.78 | 107.98 | +0.85 | +0.78% | 5.79M | NASDAQ | |||
| 154.41 | 155.66 | 148.55 | -0.32 | -0.21% | 3.56M | NYSE | |||
| 114.74 | 117.38 | 113.34 | -1.27 | -1.09% | 19.40M | NYSE | |||
| 41.69 | 42.00 | 41.13 | +0.12 | +0.29% | 19.49M | NYSE | |||
| 0.261 | 0.265 | 0.252 | -0.003 | -1.14% | 58.95K | OTC Markets |